(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
2.63% SEK 0.00390
Live Chart Being Loaded With Signals
Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease...
Stats | |
---|---|
Volumen de hoy | 299 948 |
Volumen promedio | 23.75M |
Capitalización de mercado | 10.57M |
EPS | SEK-0.00938 ( 2023-11-27 ) |
Próxima fecha de ganancias | ( SEK0 ) 2024-05-21 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.0300 |
ATR14 | SEK0 (0.00%) |
Amniotics AB (publ) Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Amniotics AB (publ) Finanzas
Annual | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK-2.30M (0.00 %) |
EPS: | SEK-0.0676 |
FY | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK-2.30M (0.00 %) |
EPS: | SEK-0.0676 |
FY | 2022 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK-1.79M (0.00 %) |
EPS: | SEK-0.300 |
FY | 2021 |
Ingresos: | SEK0.00 |
Beneficio Bruto: | SEK0.00 (0.00 %) |
EPS: | SEK-3.34 |
Financial Reports:
No articles found.
Amniotics AB (publ)
Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico